Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Clinical trial NCT06066580 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06066580
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2031-02-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.